Author: Kelly Liyakasa
Source: http://westfaironline.com
Interest: Jose Galarza, president and founder of the nascent TechnoVax, a maker of virus-like particle technology (VLP), said the company retained a $3 million Small Business Innovation Research (SBIR) grant in 2009 and $1 million in funding from the National Institutes of Health in 2005; the money will go toward clinical trials for mass-market vaccines for infectious diseases.
Link: http://westfaironline.com/2011/15882-building-biotech/
Loading...